Triple-negative breast cancer (TNBC) studies by Forero et al. corroborate these findings: elevated CIITA expression correlates with improved progression-free survival (PFS) and enhanced lymphocyte infiltration 4. The gene discussed is CIITA; the disease is triple-negative breast carcinoma.